Rett Syndrome and the Impact of MeCP2 Associated Transcriptional Mechanisms on Neurotransmission

This publication has 78 references indexed in Scilit:

• FOXG1 Is Responsible for the Congenital Variant of Rett Syndrome
  American Journal of Human Genetics, 2008
• MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
  Science, 2008
• Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes
  Proceedings of the National Academy of Sciences, 2007
• MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
  Neuron, 2007
• Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2
  Proceedings of the National Academy of Sciences, 2007
• Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation
  Neuron, 2006
• MeCP2-Dependent Transcriptional Repression Regulates Excitatory Neurotransmission
  Current Biology, 2006
• Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome
  Neurobiology of Disease, 2006
• The transcriptional repressor Mecp2 regulates terminal neuronal differentiation
  Molecular and Cellular Neuroscience, 2004
• Dynamics of demethylation and activation of the α-actin gene in myoblasts
  Cell, 1990